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Foreword 
The present report aims to provide a comprehensive picture of the pandemic situation of COVID-19 in the 
EU countries, and to be able to foresee the situation in the next coming days. 
We employ an empirical model, verified with the evolution of the number of confirmed cases in previous 
countries where the epidemic is close to conclude, including all provinces of China. The model does not 
pretend to interpret the causes of the evolution of the cases but to permit the evaluation of the quality of 
control measures made in each state and a short-term prediction of trends. Note, however, that the effects 
of the measures’ control that start on a given day are not observed until approximately 7-10 days later. 
 The model and predictions are based on two parameters that are daily fitted to available data: 
 a: the velocity at which spreading specific rate slows down; the higher the value, the better the 
control.  
 K: the final number of expected cumulated cases, which cannot be evaluated at the initial stages 
because growth is still exponential. 
We show an individual report with 8 graphs and a table with the short-term predictions for different 
countries and regions. We are adjusting the model to countries and regions with at least 4 days with more 
than 100 confirmed cases and a current load over 200 cases. The predicted period of a country depends on 
the number of datapoints over this 100 cases threshold, and is of 5 days for those that have reported more 
than 100 cumulated cases for 10 consecutive days or more. For short-term predictions, we assign higher 
weight to last 3 points in the fittings, so that changes are rapidly captured by the model. The whole 
methodology employed in the inform is explained in the last pages of this document. 
In addition to the individual reports, the reader will find an initial dashboard with a brief analysis of the 
situation in EU-EFTA-UK countries, some summary figures and tables as well as long-term predictions for 
some of them, when possible. These long-term predictions are evaluated without different weights to data-
points. We also discuss a specific issue every day.  
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Situation and highlights 
The EPG is a good index for assessing 
the epidemiological status of a country. 
We found that EPG>100 corresponds to 
complex situations where test and trace 
strategy is very difficult as the unique 
way to control it, and that EPG<30 
corresponds to a low risk 
epidemiological situation. Between 30 
and 100 we can talk about an 
intermediate risk situation. Obviously, 
the best scenario would be EPG = 0, but 
for now it is a difficult goal. In any case, 
although ρ7 is greater than 1 in most 
countries, the EPG is still low enough. 
Currently only Luxembourg is in a very 
complicated situation (EPG=332). It is a 
small country with a lot of mobility. It is to be hoped that the measures they implement will help controlling 
the situation. Romania (83), Spain (70) and Bulgaria (50) are in a medium risk area, although regional 
diversity in the value of EPG is very important, showing areas with higher values. Sweden, Belgium and the 
Czech Republic have EPGs between 30 and 40, close to a good epidemiological situation. We especially 
celebrate the evolution of Sweden, which has been in a very bad situation ast months. The remaining 
countries have an EPG equal to or less than 30. 
We include again the individual report of United Kingdom. We have manually corrected the initial part of the 
curve by projecting backwards the last part, using data from https://coronavirus-staging.data.gov.uk/. In 
particular, we have used the correlation between “pillar 1” and “pillar 2” temporal data series.  
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(1) ρ7 is the average of 7 consecutive ρ, but can still fluctuate. (2,3) EPG stands for Effective Growth Potential. EPGREP is the product of attack-rate of last 14 days per 105 inhabitants by 
ρ7 (empiric reproduction number). EPGEST is the product of estimated real attack-rate of last 14 days per 105 inhabitants and ρ7. Biocom-Cov degree is an epidemiological situation 
scale based on the level of last week’s mean daily new cases (https://upcommons.upc.edu/handle/2117/189661, https://upcommons.upc.edu/handle/2117/189808). 
 
Situation and trends per country 
Table of current situation in EU countries. Colour scale is relative except when indicated, this means that it is applied independently to each column, and distinguishes 
best (green) form worst (red) situations according to each of the variables. Last column (EPGEST) is assessed with estimated real 14-day attack rate (see report from 
22/04 for details). EPGREP is calculated with data reported by countries. EPGREP and EPGEST cannot be compared between them because scales are different, but can 
be independently used for estimating risk of countries according to reported or estimated real situation, respectively.  
 
Disclaimer: estimated active cases and estimated 14-day attack rate are assessed by assuming a lethality of 1 % (see report from 20 to 24 April, #37-41). This value can change in 




Analysis: On the relation between cases and hospitalizations (I). 
Lasts weeks, there have been important discussions regarding the possibility that the virus was producing 
fewer symptoms and, consequently, was less lethal. We should notice that the mutations of the virus found 
so far do not affect any of its main characteristics regarding infectivity. The population of virus SARS-CoV-2 
that we have today has the same characteristics of the population present in March and April. We address in 
two final reports the relation between cases and hospitalizations, analyzing the relation between both and 
the delays that we observe. 
In this first assessment, we focus on the relationship between both without taking into account the possible 
delays that must exist between the rise in cases and the rise in hospitalization. The reason for this delay is 
the fact that cases going to the hospital are a fraction of those with symptoms that get worse as the days 
advance. So, in theory, a positive case with symptoms must have a bad prognosis and, eventually, lead to 
hospitalization. Making a first analysis neglecting this delay is key to have a general overview of the 
situation. From this general picture, we can go later in more detail. 
During the hardest phases of the pandemic, we observed that the number of hospital admissions was a fairly 
constant and very important fraction of the cases diagnosed. We checked this fact in different countries of 
the European Union. Currently, in many European regions, we are seeing significant new increase in the 
number of cases. However, we must note that the current epidemiological situation is very different from 
what we had weeks before1. The proof is that the corresponding number of hospitalizations is very 
different. In this analysis, we discuss, based on a specific case, how the number of hospitalizations has 
changed. As we will see, this behavior is explained by the increase in the number of daily PCR tests being 
performed. 
To make this analysis we used data from the Germans Trias i Pujol University Hospital (HUGTiP) in Badalona, 
a public hospital in the metropolitan area of Barcelona. The HUGTiP pays special attention to the 
municipalities of Badalona (220,440 inhabitants), Santa Coloma de Gramanet (119,215 inhabitants) and Sant 
Adrià del Besòs (37,097 inhabitants). They are part of the Barcelona-Nord Maresme Healthcare Management 
Area (AGA BCN Nord). Figure 1 shows the temporal evolution of the cases confirmed in this healthcare area. 
Three stages are clearly identified: (i) the great initial outbreak until 09/05 (peak), (ii) a period with a fairly 
calm situation (tail), approximately from 9/05 to 7/07, and (iii) a significant growth from 7/07, a second 
outbreak.  
 
                                                          
1 https://upcommons.upc.edu/handle/2117/327195 
Figure 1. Confirmed daily new cases in the Barcelona-Nord Maresme Healthcare Management Area (AGA 
BCN Nord), whose reference hospital is Germans Trias i Pujol (HUGTiP). 
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Figure 2 shows the daily hospitalization curve in the HUGTiP. We see that there are many similarities between 
the two curves. However, we can immediately identify that the increase in the hospitalizations during the 
last days is fairly small compared with the increase in confirmed cases observed figure 1. It is very 
enlightening to represent the daily confirmed cases and the daily hospitalization one against the other. 
 
 
When representing the daily confirmed cases (x-axis) and the daily hospitalizations (y-axis), we find that there 
is a clear correlation between these two parameters, although with a different behavior before and after 




The red dots show a strong correlation between the two variables. In the initial phases (peak and tail), 53% 
of people diagnosed were being hospitalized, as we see in the figure 4. 
Figure 2. Daily hospitalizations in Germans Trias i Pujol hospital (HUGTiP). 
Figure 3. Scatter plot of daily hospitalizations (y-axis, HUGTiP) vs new cases (x-axis, BCN-Nord). In red, 







The correlation of points after 7/07 is also good although, at the moment, we do not have enough points to 
make good statistics. Figure 5 shows how hospitalizations also grow with the number of cases diagnosed but 
they do so much more slowly. Right now, the number of detected cases that require hospitalization are 
roughly 3% of cases. This reflects that many more people are currently being diagnosed, most of them being 




The main difference, as we have reported before, is that the number of PCR tests is larger. Similarly, the 
diagnostic rate is way higher. Early in March, only very serious cases were detected, and mostly around 
hospitals. Now, cases are detected around primary care. Mild symptomatic cases get PCR test. People related 
to positive cases, if considered as possible spreaders, are tested as well, even without symptoms. This is the 
explanation behind the low level of hospitalization and not a virus becoming milder. 
In the current situation, where many more diagnostic tests are being performed, it is still possible to use the 
incidence to assess hospital needs, but it is necessary to evaluate the relationship between cases and 
hospitalizations to verify the proportion between the two variables. This study is performed only with data 
from a particular case and with few points during the second growth, therefore, the numerical results are 
not directly generalizable. In the next assessment we will deal with southern US states where more 
longitudinal data is available. We will also check how the correlations between cases and hospitalization 
improve when delays are introduced between both. 
Figure 4. Correlation between daily hospitalizations in HUGTiP and confirmed new cases in BCN-Nord 
during first and second stages (first wave and tail), before 7th July. The slope indicates the percentage of 
diagnosed cases that required hospitalization (53 %).  
Figure 5. Correlation between daily hospitalizations in HUGTiP and confirmed new cases in BCN-Nord 
after 7th July, at the beginning of the new outbreak. The slope indicates the percentage of diagnosed 
cases that required hospitalization (3 %).  
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(1) ρ7 is the average of 7 consecutive ρ, but can still fluctuate. (2,3) EPG stands for Effective Growth Potential. EPGREP is the product of attack-rate of last 14 days per 105 inhabitants by 
ρ7 (empiric reproduction number). EPGEST is the product of estimated real attack-rate of last 14 days per 105 inhabitants and ρ7. Biocom-Cov degree is an epidemiological situation 
scale based on the level of last week’s mean daily new cases (https://upcommons.upc.edu/handle/2117/189661, https://upcommons.upc.edu/handle/2117/189808). 
 
Situation and trends in other countries 
Table of current situation in a sample of non-EU countries. Colour scale is relative except when indicated, this means that it is applied independently to each column, 
and distinguishes best (green) form worst (red) situations according to each of the variables. EPGREP and EPGEST cannot be compared between them because scales 
are different, but can be independently used for estimating risk of countries according to reported or estimated real situation, respectively.  
 
Disclaimer: estimated active cases and estimated 14-day attack rate are assessed by assuming a lethality of 1 % (see report from 20 to 24 April, #37-41). This value can change in 




Time indicators by country 
These tables summarize a few time indicators for each country: time since 50 cases were reported, time 
interval between an attack rate of 1/105 inhabitants and an attack rate of 10/105 inhabitants, and time 
interval between attack rates of 10 to 100 per 105 inhabitants (only for countries that have overtaken this 


















Situation and trends in Italian and Spanish regions 
Italy 





Disclaimer: estimated active cases and estimated 14-day attack rate are assessed by assuming a lethality of 1 % (see 
report from 20 to 24 April, #37-41). This value can change in countries where suspicious deaths are reported as well 
(real values would be lower) and in countries where incidence among elderly people was minor (real values would be 
higher).  
 (1) ρ7 is the average of 7 consecutive ρ, but can still fluctuate. (2,3) EPG stands for Effective Growth Potential. EPGREP is the 
product of attack-rate of last 14 days per 105 inhabitants by ρ7 (empiric reproduction number). EPGEST is the product of 
estimated real attack-rate of last 14 days per 105 inhabitants and ρ7. Biocom-Cov degree is an epidemiological situation 
scale based on the level of last week’s mean daily new cases (https://upcommons.upc.edu/handle/2117/189661, 
https://upcommons.upc.edu/handle/2117/189808). 
 
Long-term predictions are not shown any more, since all Italian and Spanish regions are already in the tail 




Legend: Countries’ reports details 
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Data obtained from  https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases  
 


































































Data obtained from https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases  
 
(2) Analysis and prediction of COVID-19 


























 Data obtained from: https://github.com/pcm-dpc/COVID-19/tree/master/dati-andamento-nazionale 
(3) Analysis and prediction of COVID-19

























































(1) Data source 
Data are daily obtained from World Health Organization (WHO) surveillance reports2, from European Centre 
for Disease Prevention and Control (ECDC)3 and from Ministerio de Sanidad4. These reports are converted 
into text files that can be processed for subsequent analysis. Daily data comprise, among others: total 
confirmed cases, total confirmed new cases, total deaths, total new deaths. It must be considered that the 
report is always providing data from previous day. In the document we use the date at which the datapoint 
is assumed to belong, i.e., report from 15/03/2020 is giving data from 14/03/2020, the latter being used in 
the subsequent analysis.  
(2) Data processing and plotting 
Data are initially processed with Matlab in order to update timeseries, i.e., last datapoints are added to 
historical sequences. These timeseries are plotted for EU individual countries and for the UE as a whole: 
 Number of cumulated confirmed cases, in blue dots 
 Number of reported new cases 
 Number of cumulated deaths  
Then, two indicators are calculated and plotted, too: 
 Number of cumulated deaths divided by the number of cumulated confirmed cases, and reported as 
a percentage; it is an indirect indicator of the diagnostic level. 
 ρ: this variable is related with the reproduction number, i.e., with the number of new infections 
caused by a single case. It is evaluated as follows for the day before last report (t-1): 
𝜌𝜌(𝑡𝑡 − 1) =
𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡 − 1) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡 − 2)
𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡 − 5) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡 − 6) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡 − 7)
 
where Nnew(t) is the number of new confirmed cases at day t.  
(3) Classification of countries according to their status in the epidemic cycle 
The evolution of confirmed cases shows a biphasic behaviour:  
(I) an initial period where most of the cases are imported; 
(II) a subsequent period where most of new cases occur because of local transmission.  
Once in the stage II, mathematical models can be used to track evolutions and predict tendencies. Focusing 
on countries that are on stage II, we classify them in three groups: 
• Group A: countries that have reported more than 100 cumulated cases for 10 consecutive days or 
more; 
• Group B: countries that have reported more than 100 cumulated cases for 7 to 9 consecutive days; 
• Group C: countries that have reported more than 100 cumulated cases for 4 to 6 days. 
 








(4) Fitting a mathematical model to data 
Previous studies have shown that Gompertz model5 correctly describes the Covid-19 epidemic in all analysed 
countries. It is an empirical model that starts with an exponential growth but that gradually decreases its 
specific growth rate. Therefore, it is adequate for describing an epidemic that is characterized by an initial 
exponential growth but a progressive decrease in spreading velocity provided that appropriate control 
measures are applied.   
Gompertz model is described by the equation:  





where N(t) is the cumulated number of confirmed cases at t (in days), and N0 is the number of cumulated 
cases the day at day t0. The model has two parameters: 
 a is the velocity at which specific spreading rate is slowing down; 
 K is the expected final number of cumulated cases at the end of the epidemic. 
This model is fitted to reported cumulated cases of the UE and of countries in stage II that accomplish two 
criteria: 4 or more consecutive days with more than 100 cumulated cases, and at least one datapoint over 
200 cases. Day t0 is chosen as that one at which N(t) overpasses 100 cases. If more than 15 datapoints that 
accomplish the stated criteria are available, only the last 15 points are used. The fitting is done using Matlab’s 
Curve Fitting package with Nonlinear Least Squares method, which also provides confidence intervals of 
fitted parameters (a and K) and the R2 of the fitting. At the initial stages the dynamics is exponential and K 
cannot be correctly evaluated. In fact, at this stage the most relevant parameter is a. Fitted curves are 
incorporated to plots of cumulative reported cases with a dashed line. Once a new fitting is done, two plots 
are added to the country report: 
 Evolution of fitted a with its error bars, i.e., values obtained on the fitting each day that the analysis 
has been carried out;  
 Evolution of fitted K with its error bars, i.e., values obtained on the fitting each day that the analysis 
has been carried out; if lower error bar indicates a value that is lower than current number of cases, 
the error bar is truncated. 
These plots illustrate the increase in fittings’ confidence, as fitted values progressively stabilize around a 
certain value and error bars get smaller when the number of datapoints increases. In fact, in the case of 
countries, they are discarded and set as “Not enough data” if a>0.2 day-1, if K>106 or if the error in K 
overpasses 106. 
It is worth to mention that the simplicity of this model and the lack of previous assumptions about the Covid-
19 behaviour make it appropriate for universal use, i.e., it can be fitted to any country independently of its 
socioeconomic context and control strategy. Then, the model is capable of quantifying the observed 
dynamics in an objective and standard manner and predicting short-term tendencies.  
(5) Using the model for predicting short-term tendencies 
The model is finally used for a short-term prediction of the evolution of the cumulated number of cases. The 
predictions increase their reliability with the number of datapoints used in the fitting. Therefore, we consider 
three levels of prediction, depending on the country: 
                                                          




• Group A: prediction of expected cumulated cases for the following 3-5 days6; 
• Group B: prediction of expected cumulated cases for the following 2 days; 
• Group C: prediction of expected cumulated cases for the following day. 
The confidence interval of predictions is assessed with the Matlab function predint, with a 99% confidence 
level. These predictions are shown in the plots as red dots with corresponding error bars, and also gathered 
in the attached table. For series longer than 9 timepoints, last 3 points are weighted in the fitting so that 
changes in tendencies are well captured by the model. 
(6) Estimating non-diagnosed cases 
Lethality of Covid-19 has been estimated at around 1 % for Republic of Korea and the Diamond Princess 
cruise. Besides, median duration of viral shedding after Covid-19 onset has been estimated at 18.5 days for 
non-survivors7 in a retrospective study in Wuhan. These data allow for an estimation of total number of 
cases, considering that the number of deaths at certain moment should be about 1 % of total cases 18.5 days 
before. This is valid for estimating cases of countries at stage II, since in stage I the deaths would be mostly 
due to the incidence at the country from which they were imported. We establish a threshold of 50 reported 
cases before starting this estimation.  
Reported deaths are passed through a moving average filter of 5 points in order to smooth tendencies. Then, 
the corresponding number of cases is found assuming the 1 % lethality. Finally, these cases are distributed 
between 18 and 19 days before each one.  
 
                                                          
6 At this moment we are testing predictions at 4 days for countries with more than 100 cumulated cases for 13-15 
consecutive days, and 5 days for 16 or more days.  
7 Zhou et al., 2020. Clinical course and risk factors for mortality of adult 
inpatients with COVID-19 in Wuhan, China: a retrospective 
cohort study. The Lancet; March 9, doi: 10.1016/S0140-6736(20)30566-3 
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